United States: June 2016 IPO Market Review

Last Updated: September 2 2016
Article by David Westenberg

June mustered only seven IPOs, down from 15 IPOs in May, and in sharp contrast to the preceding two years—in both 2014 and 2015, June produced the highest monthly IPO count of the year, with 30 and 33 IPOs, respectively. The June 2016 tally brings the number of IPOs over the first half of the year to 37—the fourth lowest half-year total in at least 20 years, trailing only 2003 (seven IPOs), 2009 (12 IPOs) and 2008 (21 IPOs).

Gross proceeds in June were $590.0 million, bringing the total for the first half of the year to $6.04 billion, 55% below the $13.41 billion raised over the first six months of 2015.

IPOs by life sciences companies accounted for four of the month's new offerings. In the first half of the year, life sciences companies have produced 20 IPOs, or 54% of the year-to-date total, up from 40% and 47% in 2014 and 2015, respectively.

IPOs by emerging growth companies (EGCs) have accounted for 81% of the year's IPOs, down from 93% of the total in 2015 and 85% of all IPOs in 2014.

The median IPO offering size over the first half of 2016 was $91.0 million, just shy of the $91.7 million for all IPOs in 2015, and 9% below the $101.0 million figure for the five-year period preceding 2015.

The median annual revenue of IPO companies through the first half of 2016 was $32.0 million, 15% below the $37.8 million median figure for 2015, and almost two-thirds below the $92.7 million median figure for the five-year period from 2010 to 2014.

The median annual revenue of life sciences IPO companies through the first half of 2016 was $0.9 million, compared to $435.7 million for all other companies. Over the five-year period preceding 2016, the median annual revenue of life sciences IPO companies was $1.5 million, while the median annual revenue of all other IPO companies was $154.0 million. The comparatively high figure for non-life sciences IPO companies in 2016 is partly attributable to the presence of large private equity–backed IPO companies within an overall small sample size of non-life sciences IPO companies.

None of June's IPO companies were profitable. Over the first half of 2016, only a dozen IPO companies—or 32% of the total—were profitable. While the 2016 profitability figure falls between the 36% in 2014 and 30% in 2015, it remains well below the 54% that prevailed over the five-year period preceding 2014.

The lower profitability figures over the last three years have been largely driven by the large number of life sciences company IPOs. Over the first half of 2016, no life sciences IPO companies were profitable, compared to 71% of the 17 non-life sciences IPO companies being profitable.

Year to date, the average IPO has produced a first-day gain of 8%, with 30% of IPOs "broken" (IPOs whose stock closes below the offering price on their first day). In comparison, the average first-day gains in 2014 and 2015 were 14% and 16%, respectively, and broken IPOs represented 27% and 26% of those year's tallies, respectively.

At June 30, the average IPO company was trading 19% above its offering price, having produced a gain of almost 10% from its first-day close. In contrast, while the average IPO company in 2015 produced a first-day gain double that of the average IPO company in the first half of 2016, by the end of 2015 that gain had been entirely erased, with the average 2015 IPO company ending the year down less than 1% from its offering price.

IPO activity in June consisted of offerings by the following companies listed in the order they came to market:

  • Clearside Biomedical, a late-stage clinical biopharmaceutical company developing first in-class drug therapies to treat blinding diseases of the eye, priced at the expected price and ended its first day of trading with a gain of 4%.
  • Nant Health, a leading next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses, priced at the midpoint of the range and produced a first-day gain of 33%.
  • Sensus Healthcare, a medical device company specializing in the treatment of non melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, priced an upsized IPO below the range and gained 17% in first-day trading.
  • Atkore International Group, a leading manufacturer of electrical raceway products primarily for the non-residential construction and renovation markets and mechanical products and solutions for the construction and industrial markets, priced below the range and was flat in first-day trading.
  • China Online Education Group, a leading online education platform in China, with core expertise in English education, priced at the midpoint of the range and ended its first day of trading down two cents from its offering price.
  • Twilio, a developer of software that enables developers to embed voice, messaging, video and authentication capabilities into their applications via its simple-to-use application programming interfaces, priced above the range—the first company to do so since December—and jumped 92% in first-day trading.
  • Syros Pharmaceuticals, a biopharmaceutical company pioneering an understanding of the region of the genome controlling the activation and repression of genes, priced below the range and gained 45% on its first day of trading.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions